Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function

Circ Res. 2002 Jun 14;90(11):1159-66. doi: 10.1161/01.res.0000020401.61826.ea.

Abstract

We aimed to elucidate the possible role of phenotypic alterations and oxidative stress in age-related endothelial dysfunction of coronary arterioles. Arterioles were isolated from the hearts of young adult (Y, 14 weeks) and aged (A, 80 weeks) male Sprague-Dawley rats. For videomicroscopy, pressure-induced tone of Y and A arterioles and their passive diameter did not differ significantly. In A, arterioles L-NAME (a NO synthase blocker)-sensitive flow-induced dilations were significantly impaired (Y: 41+/-8% versus A: 3+/-2%), which could be augmented by superoxide dismutase (SOD) or Tiron (but not L-arginine or the TXA(2) receptor antagonist SQ29,548). For lucigenin chemiluminescence, O(2)(.-) generation was significantly greater in A than Y vessels and could be inhibited with SOD and diphenyliodonium. NADH-driven O(2)(.-) generation was also greater in A vessels. Both endothelial and smooth muscle cells of A vessels produced O(2)(.-) (shown with ethidium bromide fluorescence). For Western blotting, expression of eNOS and COX-1 was decreased in A compared with Y arterioles, whereas expressions of COX-2, Cu/Zn-SOD, Mn-SOD, xanthine oxidase, and the NAD(P)H oxidase subunits p47(phox), p67(phox), Mox-1, and p22(phox) did not differ. Aged arterioles showed an increased expression of iNOS, confined to the endothelium. Decreased eNOS mRNA and increased iNOS mRNA expression in A vessels was shown by quantitative RT-PCR. In vivo formation of peroxynitrite was evidenced by Western blotting, and immunohistochemistry showing increased 3-nitrotyrosine content in A vessels. Thus, aging induces changes in the phenotype of coronary arterioles that could contribute to the development of oxidative stress, which impairs NO-mediated dilations.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt / pharmacology
  • Aging / physiology*
  • Animals
  • Arginine / pharmacology
  • Arterioles / drug effects
  • Arterioles / metabolism
  • Arterioles / physiology*
  • Blotting, Western
  • Bridged Bicyclo Compounds, Heterocyclic
  • Coronary Vessels / drug effects
  • Coronary Vessels / metabolism
  • Coronary Vessels / physiology*
  • Enzyme Inhibitors / pharmacology
  • Fatty Acids, Unsaturated
  • Hydrazines / pharmacology
  • Immunohistochemistry
  • In Vitro Techniques
  • Male
  • Multienzyme Complexes / metabolism
  • NADH, NADPH Oxidoreductases / metabolism
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitrates / blood
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase / genetics
  • Nitric Oxide Synthase / metabolism
  • Nitrites / blood
  • Oxidative Stress / physiology*
  • Phenotype
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species / metabolism
  • Superoxide Dismutase / metabolism
  • Superoxide Dismutase / pharmacology
  • Tyrosine / analogs & derivatives*
  • Tyrosine / metabolism
  • Vasodilation / drug effects
  • Xanthine Oxidase / metabolism

Substances

  • Bridged Bicyclo Compounds, Heterocyclic
  • Enzyme Inhibitors
  • Fatty Acids, Unsaturated
  • Hydrazines
  • Multienzyme Complexes
  • Nitrates
  • Nitrites
  • RNA, Messenger
  • Reactive Oxygen Species
  • 3-nitrotyrosine
  • Tyrosine
  • 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt
  • SQ 29548
  • Arginine
  • Nitric Oxide Synthase
  • Superoxide Dismutase
  • Xanthine Oxidase
  • NADH oxidase
  • NADH, NADPH Oxidoreductases
  • NG-Nitroarginine Methyl Ester